Drugs / Ecklonia cava Phlorotannin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04141241 | Mar 2016 → May 2018 | type 2 diabetes mellitus | Bota Bio Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ecklonia cava Phlorotannin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04141241 ↗ |
| Known as | PH100 | “PH100 (Ecklonia cava Phlorotannin) 200mg/tablet” NCT04141241 ↗ |